Next-generation sequencing role in pharmacogenetics and pharmacogenomics
Next-generation sequencing (NGS) represents an efficient and reliable method to evaluate the contribution of both common and rare...
top of page
Aug 27, 2022
WES and WGS as Cost-Effective Prenatal Tests
egSEQ Technology Whole exome sequencing (WES) and Whole genome sequencing (WGS) have been increasingly adopted as the primary prenatal...
Aug 27, 2022
Uncovering variants by utilising WES on HIV-positive population in Botswana
Although Africa is a genetically diverse continent there has not been extensive genetic disease mapping of the continent as there has...
Aug 23, 2022
Genetics and physical fitness
Both athletes and those who exercise for recreation are affected by non-contact muscle injuries which account for a large proportion of...
Aug 23, 2022
The role of egSEQ Exome in the research and diagnosis of Parkinson’s diseases
Neurology researchers are utilising our market-leading egSEQ library preparation and Exome solutions to understand genetic risk factors...
Aug 22, 2022
NGS testing for CYP gene and variation in drug responses
Among the most researched pharmacogenes is the CYP gene superfamily (Fukunaga et al., 2021), which influences drug-metabolising enzymes...
Aug 22, 2022
Oncology targeted therapy with egSEQ NGS
Personalised diagnostic and precision medicine for cancer patients involves tailoring each patient’s treatment based on the genomic...
Aug 22, 2022
Recurrence monitoring of colorectal and breast cancer patients with egSEQ Comprehensive Solid Tumour
With the continuous discovery of genetic targets correlated with recurrence risk, time to recurrence (TTC) and/or overall survival, it is...
Aug 22, 2022
egSEQ hybridisation capture with low-depth WGS as a high-throughput population genomics solution
egSEQ hybridisation capture with low-depth WGS as a cost-effective high-throughput population genomics solution.
Aug 22, 2022
Clinical use of NGS in pharmacology
Among the most researched such genes are the ones belonging to the CYP gene superfamily, which is thought to cause up to 60% of...
Aug 22, 2022
Research and screening of Alzheimer’s and Parkinson’s using egSEQ Amplicon panels
Existing diagnosis and treatment of Alzheimer’s and Parkinson’s disease occur when the disease has already progressed to a relatively...
bottom of page